Agree huge potential for AML treatment, those sellers over past few months were mainly because of trial uncertainty post trial death not directly related to our drug but that is almost fully resolved with only one more trial needing FDA approval to resume. Should be be resolved before years end imo.
None of the board (6% ownership) and institutions (36% ownership) have sold down as we are undervalued compared to peers for the trials we are undertaking. Christmas rally over 10c is on the cards imo.
- Forums
- ASX - By Stock
- PTX
- Ann: PTX to resume Clinical Trial of PTX-200 in Ovarian Cancer
Ann: PTX to resume Clinical Trial of PTX-200 in Ovarian Cancer, page-11
Featured News
Add PTX (ASX) to my watchlist
|
|||||
Last
4.5¢ |
Change
0.003(7.14%) |
Mkt cap ! $36.23M |
Open | High | Low | Value | Volume |
4.3¢ | 4.5¢ | 4.2¢ | $36.38K | 830.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 4.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.5¢ | 294491 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 0.044 |
3 | 272000 | 0.043 |
1 | 20988 | 0.042 |
5 | 324890 | 0.041 |
7 | 443294 | 0.040 |
Price($) | Vol. | No. |
---|---|---|
0.045 | 294491 | 4 |
0.046 | 98002 | 1 |
0.047 | 613389 | 3 |
0.048 | 200000 | 1 |
0.050 | 66739 | 3 |
Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
Featured News
PTX (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, CEO
Paul Long
CEO
Previous Video
Next Video
SPONSORED BY The Market Online